Data Availability Statement The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Murilo Guedes
Predicting mortality risk in dialysis: Assessment of risk factors using traditional and advanced modeling techniques within the Monitoring Dialysis Outcomes initiative
Important features using SHAP values Figure 6a shows the magnitude of the SHAP value for the top predictors identified by the XGBoost Model in a descending order of importance. Warmer colors on the figure show a higher impact of the parameter in predicting mortality, while cooler colors show a the negative (i.e., protective) impact of the parameter on predicting mortality.
Searching for the Risk-Benefit Profile of Higher Potassium Intake in CKD: Primum Non Nocere
Thank you for your help in sharing the high-quality science in JASN. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. Message Subject (Your Name) has sent you a message from American Society of Nephrology Message Body (Your Name) thought you would like to see the American Society of Nephrology web site. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Searching for the Risk-Benefit Profile of Higher Potassium Intake in CKD: Primum Non Nocere
In order to get access to the article, you must have an account. If you have an account, enter your user name and password into the boxes above. If you do not have an account, follow the instructions below to create one. Once you have purchased the article, you will have access to it for 24 hours. Steps for Creating an Account: Click the "Purchase Access" button. The page will redisplay with the following message at the top of the screen. In the message, click to create an account.
Searching for the Risk-Benefit Profile of Higher Potassium Intake in CKD: Primum Non Nocere
In order to get access to the article, you must have an account. If you have an account, enter your user name and password into the boxes above. If you do not have an account, follow the instructions below to create one. Once you have purchased the article, you will have access to it for 24 hours. Steps for Creating an Account: Click the "Purchase Access" button. The page will redisplay with the following message at the top of the screen. In the message, click to create an account.
Authors’ Reply
In order to get access to the article, you must have an account. If you have an account, enter your user name and password into the boxes above. If you do not have an account, follow the instructions below to create one. Once you have purchased the article, you will have access to it for 24 hours. Steps for Creating an Account: Click the "Purchase Access" button. The page will redisplay with the following message at the top of the screen. In the message, click to create an account.
Serum Biomarkers of Iron Stores Are Associated with Increased Risk of All-Cause Mortality and Cardiovascular Events in Nondialysis CKD Patients, with or without Anemia
Significance Statement Management of iron deficiency in patients with nondialysis CKD focuses on improving erythropoiesis. Studies in patients with heart failure with similar iron deficiency pathogenesis found that treating iron deficiency improves cardiovascular outcomes, regardless of anemia. To evaluate a possible anemia-independent association of iron stores with outcomes in individuals with nondialysis CKD, the authors studied patients in nephrology-based clinics from a multinational cohort.
Serum Biomarkers of Iron Stores Are Associated with Increased Risk of All-Cause Mortality and Cardiovascular Events in Nondialysis CKD Patients, with or without Anemia
Significance Statement Management of iron deficiency in patients with nondialysis CKD focuses on improving erythropoiesis. Studies in patients with heart failure with similar iron deficiency pathogenesis found that treating iron deficiency improves cardiovascular outcomes, regardless of anemia. To evaluate a possible anemia-independent association of iron stores with outcomes in individuals with nondialysis CKD, the authors studied patients in nephrology-based clinics from a multinational cohort.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Murilo
Contact Murilo, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack